What is the share price of Sanofi Consumer Healthcare India Ltd (SANOFICONR) today?
The share price of SANOFICONR as on 17th April 2025 is ₹4938.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sanofi Consumer Healthcare India Ltd (SANOFICONR) share?
The past returns of Sanofi Consumer Healthcare India Ltd (SANOFICONR) share are- Past 1 week: 0.14%
- Past 1 month: 2.11%
- Past 3 months: 1.82%
- Past 6 months: 2.46%
- Past 1 year: 0.71%
- Past 3 years: N/A%
- Past 5 years: 0.71%
What are the peers or stocks similar to Sanofi Consumer Healthcare India Ltd (SANOFICONR)?
The peers or stocks similar to Sanofi Consumer Healthcare India Ltd (SANOFICONR) include:What is the market cap of Sanofi Consumer Healthcare India Ltd (SANOFICONR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sanofi Consumer Healthcare India Ltd (SANOFICONR) is ₹11372.98 Cr as of 17th April 2025.What is the 52 week high and low of Sanofi Consumer Healthcare India Ltd (SANOFICONR) share?
The 52-week high of Sanofi Consumer Healthcare India Ltd (SANOFICONR) is ₹5375 and the 52-week low is ₹4211.55.What is the PE and PB ratio of Sanofi Consumer Healthcare India Ltd (SANOFICONR) stock?
The P/E (price-to-earnings) ratio of Sanofi Consumer Healthcare India Ltd (SANOFICONR) is 62.83. The P/B (price-to-book) ratio is 41.66.Which sector does Sanofi Consumer Healthcare India Ltd (SANOFICONR) belong to?
Sanofi Consumer Healthcare India Ltd (SANOFICONR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares?
You can directly buy Sanofi Consumer Healthcare India Ltd (SANOFICONR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sanofi Consumer Healthcare India Ltd
SANOFICONR Share Price
SANOFICONR Share Price Chart
How to use scorecard? Learn more
SANOFICONR Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
62.83 | 41.66 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.51 | 6.30 | 0.54% |
SANOFICONR Analyst Ratings & Forecast
Detailed Forecast from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
SANOFICONR Company Profile
Sanofi Consumer Healthcare India Ltd produces and markets a wide range of consumer healthcare products, including pharmaceuticals and nutritional products.
SANOFICONR Similar Stocks (Peers)
Compare with peersSANOFICONR Forecasts
Price
Revenue
Earnings
SANOFICONR Share Price Forecast
All values in ₹
All values in ₹
SANOFICONR Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
SANOFICONR Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
SANOFICONR
Income
Balance Sheet
Cash Flow
SANOFICONR Income Statement
Financial Year | FY 2023 | FY 2024 | TTM | |||
---|---|---|---|---|---|---|
Total Revenue | 559.50 | 737.50 | 719.20 | |||
Raw Materials | 156.40 | 169.50 | 464.00 | |||
Power & Fuel Cost | 0.20 | 0.10 | ||||
Employee Cost | 54.40 | 102.70 | ||||
Selling & Administrative Expenses | 79.40 | 104.30 | ||||
Operating & Other expenses | 48.00 | 105.70 | ||||
EBITDA | 221.10 | 255.20 | 255.20 | |||
Depreciation/Amortization | 1.80 | 4.50 | 4.50 | |||
PBIT | 219.30 | 250.70 | 250.70 | |||
Interest & Other Items | 0.00 | 3.90 | 3.90 | |||
PBT | 219.30 | 246.80 | 246.80 | |||
Taxes & Other Items | 54.40 | 65.80 | 65.80 | |||
Net Income | 164.90 | 181.00 | 181.00 | |||
EPS | 824.50 | 144.62 | 78.59 | |||
DPS | 0.00 | — | 0.00 | |||
Payout ratio | 0.00 | 0.00 | 0.00 |
SANOFICONR Company Updates
Annual report
PDFSANOFICONR Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sanofi Consumer Healthcare India Ltd | 62.83 | 41.66 | — |
Sun Pharmaceutical Industries Ltd | 43.88 | 6.26 | 0.77% |
Cipla Ltd | 29.69 | 4.57 | 0.86% |
Torrent Pharmaceuticals Ltd | 66.50 | 16.07 | 0.86% |
SANOFICONR Stock Price Comparison
Compare SANOFICONR with any stock or ETFSANOFICONR Shareholdings
SANOFICONR Promoter Holdings Trend
SANOFICONR Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
SANOFICONR Shareholding Pattern
SANOFICONR Shareholding History
Mutual Funds Invested in SANOFICONR
In last 3 months, mutual fund holding of the company has increased by 1.73%
Top 5 Mutual Funds holding Sanofi Consumer Healthcare India Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.4013% | Percentage of the fund’s portfolio invested in the stock 0.48% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 89/102 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.2515% | Percentage of the fund’s portfolio invested in the stock 0.51% | Change in the portfolio weight of the stock over the last 3 months 0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 49/96 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9804% | Percentage of the fund’s portfolio invested in the stock 0.53% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 68/76 (-2) |
Compare 3-month MF holding change on Screener
smallcases containing SANOFICONR stock
Looks like this stock is not in any smallcase yet.
SANOFICONR Events
SANOFICONR Dividend Trend
SANOFICONR has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
SANOFICONR Upcoming Dividends
No upcoming dividends are available
SANOFICONR Past Dividends
Cash Dividend
Ex DateEx DateApr 17, 2025
Dividend/Share
₹55.00
Ex DateEx Date
Apr 17, 2025
SANOFICONR Stock News & Opinions
Sanofi Consumer Healthcare India has revised the record date from 28 April 2025 to 17 April 2025 for final dividend of Rs 55 per equity share of face value of Rs 10 each for the year ended 31 December 2024. Powered by Capital Market - Live
According to an exchange filing, Mistry has decided to resign to explore new opportunities outside the organization. In addition, Rupendra Sachdev, the head of commercial operations and a senior management personnel, has also decided to step down from his current role. His resignation will be effective from the end of business hours on 30 April 2025, marking his last working day with the company. Sachdev is leaving to pursue his entrepreneurial aspirations. Sanofi Consumer Healthcare India is engaged in the consumer healthcare (CHC) business. It has a presence in allergy, physical wellness, and pain care segments through brands like Allegra, Combiflam, Avil, and DePURA. It also has brands like Festal, Baralgan, and Novalgin NU in its portfolio. The company's distribution capabilities cover channels such as distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains and e-commerce. Sanofi Consumer Healthcare India has reported 1% rise in net profit to Rs 46.35 crore on a 6.8% increase in net sales to Rs 170.70 crore in Q3 FY25 as compared with Q3 FY24. The counter shed 0.85% to Rs 4,740.15 on the BSE. Powered by Capital Market - Live
Sanofi Consumer Healthcare India announced that the 2nd Annual General Meeting(AGM) of the company will be held on 5 May 2025.Powered by Capital Market - Live
Total operating expenditure rose by 13.8% YoY to Rs 111.50 crore in Q3 FY25, due to higher finished good purchases (up 27.8% YoY) and higher other expenses (up 31.7% YoY). Profit before tax in Q3 FY25 stood at Rs 62.80 crore, up by 2.6% from Rs 61.20 crore in Q3 FY24. Tax outgo for the period under review was Rs 17.60 crore, up by 4.1% YoY. Sanofi Consumer Healthcare India is engaged in the consumer healthcare (CHC) business. It has a presence in allergy, physical wellness, and pain care segments through brands like Allegra, Combiflam, Avil, and DePURA. It also has brands like Festal, Baralgan, and Novalgin NU in its portfolio. The company's distribution capabilities cover channels such as distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains and e-commerce. The scrip slipped 1.18% to currently trade at Rs 4709.30 on the BSE. Powered by Capital Market - Live
Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at its meeting held on , inter alia, have recommended the final dividend of Rs 55 per equity Share (i.e. 550%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Sanofi Consumer Healthcare India declined 1.56% to Rs 44.30 crore in the quarter ended December 2024 as against Rs 45.00 crore during the previous quarter ended December 2023. Sales rose 6.75% to Rs 170.70 crore in the quarter ended December 2024 as against Rs 159.90 crore during the previous quarter ended December 2023. For the full year,net profit rose 9.83% to Rs 181.00 crore in the year ended December 2024 as against Rs 164.80 crore during the previous year ended December 2023. Sales rose 37.89% to Rs 724.50 crore in the year ended December 2024 as against Rs 525.40 crore during the previous year ended December 2023. ParticularsQuarter EndedYear EndedDec. 2024Dec. 2023% Var.Dec. 2024Dec. 2023% Var. Sales170.70159.90 7 724.50525.40 38 OPM %36.3839.46 -37.3541.66 - PBDT66.7063.90 4 279.70223.00 25 PBT65.7062.40 5 275.20221.00 25 NP44.3045.00 -2 181.00164.80 10 Powered by Capital Market - Live
Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 20 February 2025.Powered by Capital Market - Live
Sanofi Consumer Healthcare India has relocated its registered office to the following address with effect from 01 January 2025: Unit 1104, 11th Floor, Godrej Two, Pirojshanagar, Eastern Express Highway, Vikhroli East, Mumbai - 400079, Maharashtra, IndiPowered by Capital Market - Live
Sanofi Consumer Healthcare India announced that Surendra Agarwall, Whole-time Director and Chief Financial Officer, has tendered his resignation effective from the close of business hours of 31 December 2024 to pursue other opportunities outside of the Company.Powered by Capital Market - Live
Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant